Zdrowie i gospodarka · 23/11/2010

FDA Amends Oncologic Drugs Advisory Committee Meeting Notice

The FDA is updating the details of an Oncologic Drugs Advisory Committee meeting, originally announced on October 19, 2010, due to changes in the meeting schedule and the review of a biologics license application for Yervoy (ipilimumab) to treat advanced melanoma.